Stage I Prostate Cancer

specific

Stage I includes: (cT1a-c, cT2a, N0, M0, PSA less than 10, Grade Group 1); (pT2, N0, M0, PSA less than 10, Grade Group 1). cT1a: Prostate cancer in which the tumor is an incidental histologic finding in 5% or less of tissue resected. cT1b: Prostate cancer in which the tumor is an incidental histologic finding in more than 5% of tissue resected. cT1c: Prostate cancer in which the tumor is identified by needle biopsy found in one or both sides, but not palpable. cT2a: Prostate cancer in which the

31

Centers

2

Active Trials

Cancer Funding

Top Centers for Stage I Prostate Cancer(31)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.4
2
NCI Comprehensive
50.9
350.9
450.9
5
NCI Comprehensive
50.9
6
NCI Comprehensive
50.9
7
NCI Comprehensive
50.9
8
NCI Comprehensive
50.9
9
NCI Comprehensive
50.9
10
NCI Comprehensive
50.9
11
NCI Comprehensive
50.9
1250.9
13
NCI Comprehensive
50.9
1450.9
15
NCI Comprehensive
50.9
1650.9
1750.9
18
NCI Comprehensive
50.9
19
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
50.9
2050.9
2150.9
2250.9
2350.9
24
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
50.9
2550.9
26
NCI Comprehensive
50.9
2750.9
2850.9
2950.9
3050.9
3150.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →